Background: There is a significant increase in number of patients with type II diabetes, Quality of Life (QOL) has become a major concern. Insomnia associated with diabetes may also influence QOL in these patients. Aim: This cross sectional comparative study aims to assess QOL and its determinants inpatients with type 2 diabetes (T2DM). It also explored the prevalence and association of insomnia with QOL in T2DM patients.
INTRODUCTION
Diabetes is considered to have gained the status of a potential epidemic in India with more than 62 million individuals currently diagnosed with the disease [1, 2] . Wild et al. [3] have predicted the prevalence of diabetes to get doubled globally from 171 million to 366 million in 2030 with maximum increase in India.
Type 2 diabetes mellitus (T2DM) imposes significant burden and impairs the quality of life (QOL) [4] . Persons with T2DM report lower health-related quality of life (HRQL) than the general population [5] . HRQL is regarded as an important measure of outcome in patients with T2DM as it has been used to evaluate the impact of the disease and its treatment on individuals. Worse HRQL is associated with higher mortality in persons with T2DM [6] .
Poor sleep is a common feature of T2DM. Almost 25% of patients with sleep disorders and more than 75% patients experiencing at least one sleep symptom regularly have been reported in T2DM by Gupta and Wang [7] .
Difficulty initiating and maintaining sleep, daytime sleepiness, and poor sleep quality are some common sleep complaints encountered in patients with T2DM [8, 9] . In a recent clinical trial, sleep quality was well correlated with other diabetes QOL score [10] . Sleep disorders have been reported to influence QOL adversely in T2DM as reported by Lou et al. [11] , who have found a positive association between poor sleep quality and HRQL.
Though there is enough evidence to suggest the overall low QOL in patients with T2DM, in India, the literature on the determinants of QOL and its correlation with insomnia is not largely available. The present study was designed to assess QOL and their determinants in T2DM. It has also explored the prevalence and association of insomnia with QOL.
MATERIALS AND METHODS
This study was conducted by the Department of Psychiatry in collaboration with the Diabetes Clinic of Medicine in a secondary care referral hospital in Jaipur, India. The hospital is a multispecialty treatment facility center catering to the health needs of a defined group of the population from the entire province. Diabetes patients are evaluated in detail in routine clinical practice, and all relevant biochemical tests are performed. The nature and purpose of the study were explained to all the participants, and informed consent was obtained before their inclusion in the study sample.
The study sample comprised 50 patients of diabetes from both sexes, between the ages of 18-70 years attending the outpatient clinic of diabetes department. Equal numbers of healthy controls were also enrolled to make a comparison group. Utmost care was taken to ensure the homogeneity of the sample population by recruiting close relatives or friends of the patients as a control group. Diabetes was defined as either requiring oral or injectable antidiabetic medication or having a random blood glucose level of above 200 mg/dl.
The participants were excluded from the study if they were known: (i) to have current substance use disorder using the Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) criteria, (ii) to have current or past psychosis or mania, major depression, or any other mental disorder using the DSM-IV criteria, and (iii) to have any major medical or surgical problems before the diagnosis of diabetes.
Measures
A detailed evaluation of the sociodemographic and clinical profile was made on specially designed semistructured questionnaire by interviewing the participants for personal and sociodemographic details and obtaining information from the medical records for disease characteristics. This included the duration of illness, duration of treatment, the type of treatment, BMI, complications due to diabetes, fasting, and postprandial blood glucose levels. The participants were also assessed on Insomnia Severity Index (ISI) and WHOQOL-BREF to measure the presence of insomnia and QOL, respectively. ISI [12] is one of the most commonly used diseasespecific measures for self-perceived insomnia severity. The ISI has seven items describing insomnia-related health impairments. Each item is rated on a five-point Likert scale with scores ranging from 0 to 4, indicting 'none', 'mild', 'moderate', 'severe', and 'very severe' sleep problems, respectively. The total ISI score is calculated by summing the scores from the seven items, and range from a minimum of 0 to a maximum of 28, with higher scores reflecting more severe sleep problems. In clinical assessments, the ISI total summary score falls into one of the four ISI categories, with scores 0-7, 8-14, 15-21, and 22-28 indicating no clinically significant insomnia, subthreshold insomnia, moderate insomnia, and clinically severe insomnia, respectively. The psychometric properties of the ISI have been evaluated in earlier studies and have been reported to have sound measurement quality for measuring perceived insomnia severity and the impact of insomnia indifferent populations [13, 14] .
In our study, we used the Hindi version of the ISI [15] , which has a reliability of 0.91 and a corrected item correlation range of 0.56-0.87. The Hindi version of the SI is a self-reported, valid, and reliable tool for the measurement of severity of insomnia. A clinical cutoff score of 8 on the ISI is associated with optimal sensitivity and specificity for the detection of sleep difficulties [16] .
The WHOQOL-BREF [17] was developed by the WHOQOL Group, in 15 international field centers [17] . It is a self-report questionnaire that contains 26 items, and each item represents one facet. Among the 26 items, 24 make up the four domains of physical health (seven items), psychological health (six items), social relationships (three items), and environment (eight items). The other two items measure the overall QOL and general health. In this study, the Hindi version [18] was used. The scale has been shown to have good discriminate validity, sound content validity, and good test-retest reliability at several international WHOQOL centers. Despite the heterogeneity of facets included within domains, all domains display excellent internal consistency. Domain scores were calculated by multiplying the mean of all facet scores included in each domain by a factor of 4, with a possible range of each raw domain score of 4 to 20. Each raw domain score was then transformed to a scale ranging from 0 to 100, with a higher score indicating a higher QOL. The psychometric properties of the generic 236-item questionnaire was tested in several countries and the WHOQOL-100, Hindi tool was found to be a suitable instrument for comprehensively assessing the quality of life in health-care settings. The BREF version is shorter, simpler, and more convenient to be used in community survey and has better comprehensibility [18] .
Therefore, using the WHOQOL-BREF Hindi questionnaire in this study was suitable due to limited patient's time and busy clinical environments.
Statistical analysis
Data summarized and analyzed in MS Excel 2007 Medcalc version, 12.2.1.0 (Medcalc Software Mariakerke, Belgium) was used for the analysis of the data. univariate analysis for outcome variables of QOL, demographic profile, and insomnia. Independent unpaired t-test and analyses of variance were performed to find the association between QOL scores and various sociodemographic and clinical variables among the diabetic cases. Odds ratio was calculated to assess the degree of association of insomnia among diabetes cases and controls. The criterion for statistical significance was set at P less than 0.05 and for statistical trend at P less than 0.10.
RESULTS

Sociodemographic profile and disease characteristics of the participants
A total of 50 patients and an equal number of agematched and sex-matched controls were included in the study. The mean age of the participants was 48.25±19.05 and the mean duration of illness was 5.64±2.35 years. Among the patients, 27 (54%) were men and 27 (46%) were women. Most of the patients (80%) had been receiving treatment for more than 12 months. Thirty-three (66%) had been taking oral medication as compared with six (12%) of those receiving injections. Eleven (22%) had been receiving both oral and injectable medications. Random blood sugar levels were above normal in 38 (76%) of the study patients with the average blood glucose level measured as 153.06 mg% (SD=±59.25). Twenty-one (42%) of the patients had optimal BMI, followed by 30 and 28% being overweight and obese, respectively. Current smoking was reported in 16 (32%) of the diabetic patients.
Mean QOL score in diabetes and control groups Relationship between sociodemographic profile and disease characteristics and QOL in diabetes
The relationships of demographic variables and disease characteristics with QOL were examined ( Table 2 ). The association of demographic variables with QOL score was statistically insignificant except that women had impaired QOL than men especially in the physical domain. Among the disease characteristics, QOL scores were significantly associated with HbA1C level and patients with very good control (HbA1C level ≤6.5) had comparatively better QOL (P<0.05) in all domains than those with poor * Significant, LS: Level of significance, D: Domain control (HbA1C level≥8). Similarly, the duration of illness had significant association with poor QOL (P≤0.00). Patients who had diabetes for longer than 1 year scored significantly low than those patients with less than 1 
DISCUSSION
QOL in patients with diabetes was significantly impaired than in the healthy controls. Several studies have shown a strong negative influence of diabetes on QOL [19] [20] [21] . Furthermore, diabetic complications have been found to have an additional negative impact on QOL in such patients [22, 23] .
QOL is an important aspect in patients with diabetes. Poor QOL may be associated with decreased self-care, poor compliance, and increased complications that may exacerbate the existing illness, thus further deteriorating QOL. It also provides an opportunity to understand perceived burden in the patients and quantify the effect of treatment [24] .
Presence of insomnia in patients with diabetes predisposes them to develop further complications and may cause exacerbation of symptoms of diabetes. It is important to assess sleep quality in patients with T2DM as many patients may become aware of their sleep problems [25] .
In this study sample, more than half of the participants (62%) with diabetes had insomnia. Similar results have been reported in earlier studies. Luyster and DunbarJacob [10] reported poor sleep quality in 55% of his study population with T2DM. Some other studies have also identified poor sleep quality ranging from 33 to as high as 67% in patients with T2DM [8, 11, 26, 27] .
The underlying association between diabetes and insomnia can be explained by various factors such as hyperglycemia [2] , activation of HPA axis [28] , and impaired glucose tolerance [29] . Sleep apnea, commonly reported in diabetes [30] , may also contribute to poor sleep quality. Insomnia itself predisposes an individual with T2DM to further complications. During sleep deprivation high levels of glucose have been reported due to the reduced glucose metabolism and high cortisol level which may further aggravate diabetes [31] .
Factors affecting QOL in T2DM were also studied. Poor QOL was associated with female sex, longer duration of disease, poor glycemic control, increased BMI, and insomnia. Association between poor QOL and being women has also been reported by Manjunath et al. [32] who after deriving the mean score of QOL scale, divided the groups between good score and bad scores. The corresponding findings have also been observed by Wexler et al. [23] who studied 904 primary care patients with T2DM.
The duration of the illness also had an adverse influence on QOL in T2DM. Longer duration was associated with poor QOL. Lou et al. [11] who studied 944 patients with diabetes established a similar association. Brasil et al. [33] in his study also reported direct correlation of Diabetes Quality of Life Measure with time since the diagnosis of the illness. Longer duration is likely to be associated with poor adherence to treatment, increased complications including macrovascular and microvascular, escalation of financial burden, poor social participation, contributing to poor quality of life.
Association of poor glycemic control with impaired QOL observed in this study has also been reported in earlier studies [11, 33] . Poor glycemic control not only gives rise to several complications, but also decreases the mobility and increases the mortality influencing QOL adversely.
Decreased score of QOL scale in this study was linked with increased BMI. Several studies in the recent past have yielded similar results [34, 35] . Although this association was statistically significant with all domains of QOL, physical domain was most adversely affected with higher BMI corresponding to a qualifying score of at least 30 for obesity. Slagter et al. [35] who studied 13 686 individuals with obesity also observed the strong association of obesity with physical health domain as compared with other domains. It is postulated that individuals with obesity tend to carry more weight and have to put in much effort to perform daily activities. Moreover, obesity also predisposes an individual for several metabolic syndromes, diabetes, and other complications, thus impairing the QOL in such patients. Some studies on the contrary did not find any such correlation between obesity and impaired QOL like Manjunath et al. [32] , who cited the reason for this disparity being the small number of patients with obesity (≥30) in his study sample as most of the participants had a BMI of between 27 and 30, who may have had still a good QOL. Similarly, Wexler et al. [23] also did not find such association in his study.
Impaired QOL in our study was associated with insomnia. Lou et al. [11] has also made a similar observation in his cross-sectional study to examine sleep quality and QOL in T2DM in the Chinese population. Luyster and Dunbar-Jacob [10] also found poor sleep quality as a significant predictor of lower HRQL as indicated by a lower score on both the physical and mental component scores of SF-36. Guereje et al. [36] , who studied 2152 elderly Nigerians observed that difficulty in initiation or maintaining sleep and early morning awakening were associated with all four domains of WHOQOL-BREF and overall QOL. Insomnia causes significant impairment in social and occupational functioning, reduced capacity to work, frequent absenteeism, cognitive decline, and increased psychological comorbidities. Insomnia also aggravates the existing illness and may give rise to secondary complications affecting QOL in these patients [10] .
LIMITATIONS OF STUDY
There are some limitations to the present study. The small sample size and the cross-sectional nature of the study may limit the applicability of results in the general population. Self-reported questionnaire may have resulted in underreporting or overreporting of symptoms. Subjective sleep experience may not appropriately represent the objective sleep difficulties.
CONCLUSION
T2DM influenced QOL adversely. Insomnia tended to occur more frequently in such patients as compared with healthy population. Various disease characteristics have been associated with impaired quality of life in T2DM including the duration of disease, poor glycemic control, increased BMI, and presence of insomnia. Targeting these risk factors during the treatment of T2DM may improve the overall QOL in those patients.
